Lieberman J A, Saltz B L, Johns C A, Pollack S, Borenstein M, Kane J
Hillside Hospital, Glen Oaks, New York.
Br J Psychiatry. 1991 Apr;158:503-10. doi: 10.1192/bjp.158.4.503.
This article reviews eight published studies that describe clozapine's effects on TD and examines the outcome of 30 patients with TD treated with clozapine for up to 36 months. These data indicate that TD response to clozapine is variable but that approximately 43% of cases, particularly those with dystonic features, improved after clozapine treatment. Methodological limitations of the studies described, however, preclude definitive conclusions, which must await appropriately controlled trials.
本文回顾了八项已发表的研究,这些研究描述了氯氮平对迟发性运动障碍(TD)的影响,并考察了30例接受氯氮平治疗长达36个月的TD患者的治疗结果。这些数据表明,TD对氯氮平的反应存在差异,但约43%的病例,尤其是那些具有肌张力障碍特征的病例,在氯氮平治疗后有所改善。然而,所描述研究的方法学局限性使得无法得出明确结论,这必须等待适当的对照试验。